Main Menu

NASDAQ (usa)	6715.56	-12.11	-0.18%
FTSE 100 (london)	7487.96	-5.12	-0.07%
DAX (german)	13465.51	235.94	1.78%
NIKKEI 225 (japan)	22420.08	408.47	1.86%
Hang - Seng (hong kong)	28594.06	348.52	1.23%

NIFTY - 50 (india)
Straits Times (singapore)	3391.61	17.53	0.52%
KOSPI (korea)	2556.47	33.04	1.31%
All Ordinaries (australia)	6005.30	28.90	0.48%
BOVESPA (brazil)	74092.76	-215.73	-0.29%

CSL Ltd (ASX: CSL)

CSL Technical Analysis

As on 1st Nov 2017 CSL Share Price closed @ 140.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 124.77 & Strong Buy for SHORT-TERM with Stoploss of 133.69 we also expect STOCK to react on Following IMPORTANT LEVELS.

CSL Share Price

Open	140.00	Change	Price	%
High	141.37	1 Day	1.47	1.06
Low	139.72	1 Week	0.00	0.00
Close	140.40	1 Month	2.74	1.99
Volume	578421	1 Year	37.17	36.01
52 Week High 145.00 \| 52 Week Low 91.62

ASX Australia Most Active Stocks

COE	0.30	3.45%
GPP	0.02	0.00%
DUE	3.02	1.00%
BUR	0.02	0.00%
AGO	0.02	0.00%
BPT	1.05	7.14%
PNX	0.01	0.00%
PIO	0.03	0.00%
DJS	3.99	0.00%
KSO	0.40	3900.00%

More..

ASX Australia Top Gainers Stocks

KSO	0.40	3900.00%
XST	0.02	100.00%
XST	0.02	100.00%
ATP	0.03	50.00%
ATP	0.03	50.00%
PMQ	0.03	50.00%
RMI	0.03	50.00%
RMI	0.03	50.00%
BNV	0.03	50.00%
IRM	0.03	50.00%

More..

ASX Australia Top Losers Stocks

APP	0.20	-80.00%
APP	0.20	-80.00%
APP	0.20	-80.00%
APP	0.20	-80.00%
TCQ	0.27	-73.53%
EMG	0.01	-50.00%
EMG	0.01	-50.00%
EMG	0.01	-50.00%
EMG	0.01	-50.00%
GDY	0.01	-50.00%

More..

CSL
Daily Charts

CSL
Intraday Charts

Whats New @
Bazaartrend

CSL
Free Analysis

CSL Important Levels Intraday

SUPPORT	0.00
SUPPORT	0.00
RESISTANCE	141.93
RESISTANCE	141.30
SUPPORT	139.50
SUPPORT	138.87
SUPPORT	0.00
SUPPORT	0.00

CSL Target for Month April

4th UP TARGET	156.64
3rd UP TARGET	150.96
2nd UP TARGET	147.45
1st UP TARGET	143.94
1st DOWN TARGET	133.92
2nd DOWN TARGET	130.41
3rd DOWN TARGET	126.9
4th DOWN TARGET	121.22

CSL Weekly Target

4th UP TARGET	0.00
3rd UP TARGET	0.00
2nd UP TARGET	0.00
1st UP TARGET	0.00
1st DOWN TARGET	0.00
2nd DOWN TARGET	0.00
3rd DOWN TARGET	0.00
4th DOWN TARGET	0.00

CSL Target for Year 2021

4th UP TARGET	0
3rd UP TARGET	0
2nd UP TARGET	0
1st UP TARGET	0
1st DOWN TARGET	0
2nd DOWN TARGET	0
3rd DOWN TARGET	0
4th DOWN TARGET	0

CSL Ltd ( ASX Australia Symbol : CSL )
Sector : Healthcare And Other Stocks in Same Sector

EMG
0.01 -0.01 (-50.00 %)
LT : Strong Sell
ST : Strong Sell

SYR
3.38 0.01 (0.30 %)
LT : Buy
ST : Buy

SRI
0.01 0.00 (0.00 %)
LT : Strong Sell
ST : Strong Sell

SBM
2.99 0.09 (3.10 %)
LT : Strong Buy
ST : Strong Buy

TNG
0.16 0.02 (14.29 %)
LT : Buy
ST : Strong Buy

CSL Other Details

Segment	EQ
Market Capital	0.00
Sector	Healthcare
Industry	Biotechnology
Offical website	>

CSL Address

45 Poplar Road
Parkville, VIC 3052
Australia
Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

CSL Latest News

Your Comments and Response on CSL Ltd

CSL Business Profile

CSL Limited engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products in Australia, the United States, Switzerland, Germany, and internationally. The company operates through CSL Behring, bioCSL, and CSL Intellectual Property segments. The CSL Behring segment manufactures, markets, and develops plasma therapies, including plasma products and recombinants that are used to treat coagulation disorders, including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders, cardiac surgery, organ transplantation, and burn treatment, as well as to prevent hemolytic diseases in the newborn. The bioCSL segment manufactures and distributes non-plasma biotherapeutic products, including biological products for human use; vaccines to prevent viral and bacterial diseases; prescription pharmaceuticals to treat a range of human medical conditions; in vitro diagnostic products; and antivenoms to treat victims of venomous snake and spider bites. The CSL Intellectual Property segment engages in the commercialization of intellectual property. In addition, the company markets various vaccines and antivenoms, as well as a range of pharmaceutical products supplied by other manufacturers. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service